Toshihito Hirai
Papers
1
Total Citations
4
H-Index
1
About
Dr. Toshihito Hirai is a pioneering transplant surgeon whose research focuses on optimizing surgical outcomes for kidney transplant recipients with renal cell carcinoma. His landmark work compares robot-assisted laparoscopic partial nephrectomy with traditional open surgery for treating allograft kidney tumors, demonstrating that minimally invasive approaches can achieve comparable oncologic control while reducing recovery times in this vulnerable population. His most-cited paper, a retrospective single-center study published in 2025, has already garnered 4 citations, reflecting the growing clinical urgency to address malignancies in immunosuppressed patients. Dr. Hirai’s contributions are particularly significant given that 0.2–0.5% of kidney transplant recipients develop allograft RCC—a complication with limited surgical guidelines. By systematically evaluating robotic techniques against conventional open procedures, he provides critical evidence for balancing cancer eradication with graft preservation. His work bridges transplant medicine and surgical oncology, offering actionable insights for clinicians managing post-transplant malignancies. Dr. Hirai continues to advance the field through rigorous comparative studies, shaping best practices for this high-risk patient population.
Research Focus
Key Achievements
Top Papers
- 1